Diploma (LON:DPLM - Get Free Report) had its target price boosted by equities research analysts at Berenberg Bank from GBX 5,600 ($75.20) to GBX 5,750 ($77.21) in a research note issued on Friday,Digital Look reports. The firm presently has a "buy" rating on the stock. Berenberg Bank's target price would indicate a potential upside of 11.00% from the company's previous close.
Separately, Shore Capital reaffirmed a "hold" rating and set a GBX 5,100 ($68.48) price objective on shares of Diploma in a research note on Thursday.
Check Out Our Latest Report on Diploma
Diploma Trading Down 0.8%
Shares of DPLM traded down GBX 40 ($0.54) on Friday, reaching GBX 5,180 ($69.56). 5,596,750 shares of the company's stock were exchanged, compared to its average volume of 437,912. The business has a 50 day moving average price of GBX 4,712.35 and a two-hundred day moving average price of GBX 4,363.24. Diploma has a 12 month low of GBX 3,532 ($47.43) and a 12 month high of GBX 5,625 ($75.53). The stock has a market capitalization of £6.91 billion, a P/E ratio of 59.54, a price-to-earnings-growth ratio of 2.82 and a beta of 0.75. The company has a current ratio of 2.17, a quick ratio of 0.80 and a debt-to-equity ratio of 62.17.
Diploma (LON:DPLM - Get Free Report) last released its earnings results on Wednesday, May 21st. The company reported GBX 80.20 ($1.08) EPS for the quarter. Diploma had a net margin of 9.25% and a return on equity of 13.18%. Research analysts anticipate that Diploma will post 163.7995512 earnings per share for the current year.
Insider Transactions at Diploma
In other news, insider Katie Bickerstaffe bought 44 shares of the company's stock in a transaction that occurred on Wednesday, May 21st. The shares were acquired at an average price of GBX 4,867 ($65.36) per share, with a total value of £2,141.48 ($2,875.63). In the last three months, insiders bought 96 shares of company stock worth $473,173. 0.52% of the stock is currently owned by corporate insiders.
About Diploma
(
Get Free Report)
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Diploma, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Diploma wasn't on the list.
While Diploma currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
